These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 5521354)

  • 1. In vitro studies of BL-P1462, a new semisynthetic penicillin with anti-pseudomonas activity.
    Barza M; Berman H; Michaeli D; Molavi A; Weinstein L
    Antimicrob Agents Chemother (Bethesda); 1970; 10():341-5. PubMed ID: 5521354
    [No Abstract]   [Full Text] [Related]  

  • 2. Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.
    Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH; Jones RN
    J Antibiot (Tokyo); 1977 Dec; 30(12):1098-106. PubMed ID: 599083
    [No Abstract]   [Full Text] [Related]  

  • 3. BL-P 1654, a new broad-spectrum penicillin with marked antipseudomonal activity.
    Price KE; Leitner F; Misiek M; Chisholm DR; Pursiano TA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():17-29. PubMed ID: 5000254
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antibiotic associations on acting Pseudomonas aeruginosa].
    Duval J; Mathieu-Saint-Laurent P; Soussy CL
    Pathol Biol (Paris); 1971; 19(11):637-48. PubMed ID: 4997792
    [No Abstract]   [Full Text] [Related]  

  • 5. In vitro assessment of tobramycin, a new aminoglycoside with anti-Pseudomonas activity.
    Molavi A; Barza M; Cole W; Berman H; Weinstein L
    Chemotherapy; 1973; 18(1):7-16. PubMed ID: 4485185
    [No Abstract]   [Full Text] [Related]  

  • 6. [Resistance of enterococci to penicillin, cephalosporins and classical broad spectrum antibiotics].
    Schaal KP; Rütten D
    Med Welt; 1973 Mar; 24(11):402-5. PubMed ID: 4488109
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro antimicrobial activity of a new semisyntheti penicillin, BL-P 1654 (6-(R- -(guanylureido) phenylacetamido)-penicillanic acid).
    Van Scoy RE; Warren E; Washington JA
    Antimicrob Agents Chemother (Bethesda); 1970; 10():12-6. PubMed ID: 4939731
    [No Abstract]   [Full Text] [Related]  

  • 8. Bacteriological, pharmacological, and clinical studies of carbenicillin.
    Meyers BR; Sabbaj J; Weinstein L
    Arch Intern Med; 1970 Feb; 125(2):282-6. PubMed ID: 4983746
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative activity of furbenicillin and carbenicillin-like compounds.
    Li JT; Williams JD
    J Antimicrob Chemother; 1982 Mar; 9(3):171-81. PubMed ID: 6978880
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative in vitro evaluation of BL-P1654 and carbenicillin against Pseudomonas.
    Overturf GD; Ressler R; Wilkins J
    Antimicrob Agents Chemother; 1974 Nov; 6(5):643-6. PubMed ID: 15825320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of new antibiotics in the treatment of Pseudomonas infections. I. In vitro tests].
    Pérez Ureña MT; Iriarte MT; Fernández P
    Rev Clin Esp; 1969 May; 113(3):235-40. PubMed ID: 5348710
    [No Abstract]   [Full Text] [Related]  

  • 12. -carboxy-3-thienylmethylpenicillin (BRL 2288), a new semisynthetic penicillin: in vitro evaluation.
    Sutherland R; Burnett J; Rolinson GN
    Antimicrob Agents Chemother (Bethesda); 1970; 10():390-5. PubMed ID: 5000263
    [No Abstract]   [Full Text] [Related]  

  • 13. [Apalcillin: in vitro activity compared with that of carbenicillin, ticarcillin, mezlocillin, piperacillin against Enterobacteriaceae and Acinetobacter].
    Quentin C; Sageaux JC; Bebear C; Latrille J
    Pathol Biol (Paris); 1983 Jun; 31(6):463-6. PubMed ID: 6224123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory and clinical studies of carbenicillin against gram-negative bacilli.
    Standiford HC; Kind AC; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1968; 8():286-91. PubMed ID: 5735373
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial activity of beta-lactams against multiresistant micro-organisms from the family Enterobacteriaceae, and genus Pseudomonas.
    Niebla A; González I; Vallín C
    Microbios; 1994; 80(325):245-50. PubMed ID: 7700163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro bactericidal activity of trimethoprim combined with different antibiotics].
    Cluzel R; Sirot J; Cluzel M; Joly B
    Pathol Biol (Paris); 1972 Nov; 20(21):871-9. PubMed ID: 4566242
    [No Abstract]   [Full Text] [Related]  

  • 17. Antimicrobial activity in vitro against Pseudomonas sp.
    Brenciaglia MI; Cipriani P; Mancini C
    Antibiotica; 1972; 10(1-2):16-21. PubMed ID: 4679552
    [No Abstract]   [Full Text] [Related]  

  • 18. [Transferable resistance to azlocillin (Securopen)].
    Antal M; Krcméry V; Zikmundová V; Menkyna R; Sirági P; Výmola F
    Cesk Epidemiol Mikrobiol Imunol; 1983 Jul; 32(4):204-10. PubMed ID: 6225535
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro activity of azlocillin, carbenicillin, mezlocillin and piperacillin against Pseudomonas aeruginosa.
    Høiby N; Bremmelgaard A; Schouenborg P
    Scand J Infect Dis Suppl; 1981; 29():27-30. PubMed ID: 6458882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Behavior of hospital Serratia in the presence of several antibiotic associations].
    Brisou J; Denis F
    Pathol Biol (Paris); 1971; 19(11):655-60. PubMed ID: 4933629
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.